A Novel Full-Length Recombinant Human Complement Factor H (CFH; GEM103) for the Treatment of Age-Related Macular Degeneration Shows Similar <i>In Vitro</i> Functional Activity to Native CFH-Reference-Cited by-同舟云学术

A Novel Full-Length Recombinant Human Complement Factor H (CFH; GEM103) for the Treatment of Age-Related Macular Degeneration Shows Similar In Vitro Functional Activity to Native CFH

Published:2022-04-03 Issue:7 Volume:47 Page:1087-1093
ISSN:0271-3683
Container-title:Current Eye Research
language:en
Short-container-title:Current Eye Research

Author:

Biggs Robyn M.¹^ORCID,Makou Elisavet²,Lauder Scott¹,Herbert Andrew P.²,Barlow Paul N.²³,Katti Suresh K.¹

Affiliation:

1. Gemini Therapeutics Inc., Cambridge, MA, USA

2. School of Chemistry, University of Edinburgh, Edinburgh, UK

3. School of Biological Sciences, University of Edinburgh, Edinburgh, UK

Funder

Gemini Therapeutics, Inc

Publisher

Informa UK Limited

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02713683.2022.2053725

Reference36 articles.

1. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study

2. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis

3. Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression

4. Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-related Macular Degeneration

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation;Blood Advances;2024-08-02

2. Complement factor H in molecular regulation of angiogenesis;Medical Review;2024-07-01

3. Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity;Frontiers in Immunology;2024-05-10

4. PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration;Pharmaceuticals;2024-04-17

5. Gliosis-dependent expression of complement factor H truncated variants attenuates retinal neurodegeneration following ischemic injury;Journal of Neuroinflammation;2024-02-22